Contact Hours 1.00
CERP A 1.00
Pharmacology Hours 0.30
Expires Dec 31, 2028
Topics: Cardiovascular, Pharmacology
Population: Adult
Role: APRN, Staff
Member: Free
NonMember: $10.00
NTI Recorded Session NTI26249
Author(s): Leora E Shachat, RN, MSN; Grace M Lomibao, MSN, AGACNP-BC, AGCNS-BC, CCRN; Irina Skrebtsova, RN, MSN, APRN, ACNP
Contact Hours 1.00
CERP A 1.00
Pharmacology Hours 0.30
Expires Dec 31, 2028
Topics: Cardiovascular, Pharmacology
Population: Adult
Role: APRN, Staff
Before you Begin
1. Reflect on the following question: What new knowledge or perspective do you hope to gain from this activity?
2. Review: Implicit Bias and its Impact on Patient Outcomes (License requirement for California)
Description
Explore the APRN’s critical role in the initial management of acute aortic pathology prior to surgery. This session reviews current guidelines, diagnostic imaging, and pharmacologic strategies for patient stabilization. Analysis of case study imaging strengthens the attendee’s ability to recognize high-risk features and make timely decisions. This session is designed for APRNs aiming to enhance diagnostic and pharmacologic expertise. Pharmacology content = 30%Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.
AccreditationAmerican Association of Critical-Care Nurses is accredited as a provider of
nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for
{contactHours} contact hours.
The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.
Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.
Refund PolicyContinuing Education Activities are nonrefundable.